Reprint article of ChinaDaily：http://www.chinadaily.com.cn/a/201806/21/WS5b2b0be2a3103349141dd7bf_2.html
Zeng Bing (L), deputy general manager of Sinopharm, visits China National of Traditional
& Herbal Medicine Co, Ltd. [Photo by Li Yuefeng/chinadaily.com.cn]
Sinopharm, a large medicine group controlled by China’s State-owned Asset Supervision and Administration Commission of the State Council, is promoting mixed ownership reform in its Traditional Chinese Medicine (TCM) branch.
“Sinopharm has been a pilot of mixed ownership reform and accumulated lots of experience in the field,” said Zeng Bing, deputy general manager of Sinopharm.
“Traditional Chinese Medicine now is developing rapidly, and great efforts of mixed ownership reform will be continuously put on this area when we boost the whole industrial chain layout.”
Herbal medicine base of China National of Traditional & Herbal Medicine Co, Ltd.
[Photo by Li Yuefeng/chinadaily.com.cn]
He also said that Sinopharm’s TCM mixed ownership reform is productive.
Currently, 90 percent of businesses controlled by China National of Traditional & Herbal Medicine Co, Ltd. are already listed, and in the future, it will absorb more private capital to realize a diversity of equities.
China National of Traditional & Herbal Medicine Co, Ltd. was formerly known as Yingtian Medicine.
As early as 2013, Sinopharm acquired shares of the private company, Yingtian Medicine, to strengthen its TCM market competitiveness and realize all-round development of the TCM industrial chain.
Zhang Yue contributed to this story.